Mission Creek Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History

Mission Creek Capital Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$245K	Buy	+4,250	New	+$244K	0.04%	203
2024 Q3	–	Sell	-5,094	Closed	-$212K	–	224
2024 Q2	$212K	Sell	5,094 -10,909	-68%	-$488K	0.05%	200
2024 Q1	$868K	Sell	16,003 -10,558	-40%	-$538K	0.23%	118
2023 Q4	$1.36M	Buy	26,561 +1,270	+5%	+$66.7K	0.35%	84
2023 Q3	$1.47M	Buy	25,291 +1,130	+5%	+$69.2K	0.49%	63
2023 Q2	$1.55M	Buy	24,161 +3,326	+16%	+$223K	0.5%	63
2023 Q1	$1.44M	Buy	20,835 +4,359	+26%	+$307K	0.49%	74
2022 Q4	$1.19M	Buy	16,476 +110	+0.7%	+$8.29K	0.42%	83
2022 Q3	$1.16M	Buy	16,366 +938	+6%	+$68K	0.44%	81
2022 Q2	$1.19M	Buy	15,428 +251	+2%	+$19.1K	0.4%	90
2022 Q1	$1.11M	Buy	15,177 +833	+6%	+$55.9K	0.3%	108
2021 Q4	$894K	Buy	14,344 +474	+3%	+$27.8K	0.18%	140
2021 Q3	$821K	Buy	13,870 +1,103	+9%	+$72.6K	0.15%	140
2021 Q2	$853K	Buy	12,767 +3,941	+45%	+$257K	0.14%	125
2021 Q1	$557K	Buy	8,826 +622	+8%	+$38.7K	0.08%	149
2020 Q4	$509K	Buy	8,204 +2,878	+54%	+$177K	0.16%	143
2020 Q3	$321K	Buy	5,326 +660	+14%	+$39.7K	0.13%	169
2020 Q2	$274K	Sell	4,666 -344	-7%	-$20.6K	0.14%	143
2020 Q1	$279K	Sell	5,010 -46	-0.9%	-$2.81K	0.15%	134
2019 Q4	$325K	Buy	+5,056	New	+$290K	0.15%	148

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mission Creek Capital Partners's BMY Position: Q2 2026 in Review

Mission Creek Capital Partners opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 4,250 shares worth $245K. The stake represents 0.04% of the portfolio and ranks #203 among its holdings. This is a return to the name: Mission Creek Capital Partners previously reported a position in BMY as recently as Q2 2024.

Mission Creek Capital Partners first reported a position in BMY in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.55M in Q2 2023. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Mission Creek Capital Partners held 4,250 shares of Bristol-Myers Squibb worth $245K as of Q2 2026.
Bristol-Myers Squibb was a new Mission Creek Capital Partners position in Q2 2026.
Bristol-Myers Squibb made up 0.04% of Mission Creek Capital Partners's portfolio in Q2 2026, its #203 holding.
Mission Creek Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 20 quarters since.
Mission Creek Capital Partners's Bristol-Myers Squibb position peaked at $1.55M in Q2 2023.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Mission Creek Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.